Inactive Instrument

Akorn, Inc.

AKRXQ

US0097281069

AKORN INC : Other Events (form 8-K)

January 27, 2020 at 10:09 pm

p style="font: 14pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

Form 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Latest news about Akorn, Inc.

Motion for Case Conversion Filed by Akorn Holding Company LLC	06-21	CI
Motion for Asset Sale Approved for Akorn Holding Company LLC	11-01	CI
Motion for Asset Sale Approved for Akorn Holding Company LLC	16/10/23	CI
Motion for Asset Sale Filed by Akorn Holding Company LLC	11/10/23	CI
Motion for Asset Sale Approved for Akorn Holding Company LLC	14/08/23	CI
Motion for Asset Sale Approved for Akorn Holding Company LLC	08/06/23	CI
Motion for Asset Sale Approved for Akorn Holding Company LLC	08/06/23	CI
Motion for Asset Sale Approved for Akorn Holding Company LLC	08/06/23	CI
Motion for Asset Sale Approved for Akorn Holding Company LLC	08/06/23	CI
Motion for Asset Sale Approved for Akorn Holding Company LLC	08/06/23	CI
Motion for Asset Sale Approved for Akorn Holding Company LLC	08/06/23	CI
Motion for Asset Sale Approved for Akorn Holding Company LLC	08/06/23	CI
Motion for Asset Sale Approved for Akorn Holding Company LLC	08/06/23	CI
Motion for Asset Sale Approved for Akorn Holding Company LLC	31/05/23	CI
Motion for Asset Sale Approved for Akorn Holding Company LLC	25/05/23	CI
Motion for Asset Sale Approved for Akorn Holding Company LLC	19/05/23	CI
Notice of successful bidders Filed for Akorn Holding Company LLC	18/05/23	CI
Bidding Procedure Approved for Akorn Holding Company LLC	28/04/23	CI
Motion for Asset Sale Filed by Akorn Holding Company LLC	20/04/23	CI
Motion for Joint Administration Approved for Akorn Holding Company LLC	20/03/23	CI
Motion for Joint Administration Filed by Akorn Holding Company LLC	17/03/23	CI
Akorn Holding Company LLC Filed for Bankruptcy	23/02/23	CI
Akorn Operating Company LLC Introduces Generic Cetrorelix Acetate for Injection 0.25 Mg	27/10/22	CI
Akorn Operating Company LLC Receives FDA Approval for Generic Version of Cetrorelix Acetate for Injection, 0.25 Mg	16/08/22	CI
Laboratoires THEA S.A.S completed the acquisition of Portfolio of Seven Branded Ophthalmic Products from Akorn Operating Company LLC.	07/03/22	CI

Akorn Inc. (Akorn), together with its subsidiaries, is a specialty generic pharmaceutical company that develops, manufactures and markets generic and branded prescription pharmaceuticals, as well as private-label over-the-counter (OTC) consumer health products and animal health pharmaceuticals. The Company operates through two segments: Prescription Pharmaceuticals and the Consumer Health. The Prescription Pharmaceuticals segment consists of generic and branded prescription pharmaceuticals in a range of dosage forms, including sterile ophthalmics, injectables and inhalants and non-sterile oral liquids, topicals and nasal sprays and otics. The Consumer Health segment consists of branded and private-label OTC products and animal health products dispensed by veterinary professionals. Its branded and private-label OTC products are focused on ophthalmics, including a dry eye treatment TheraTears Therapy for Your Eyes.

Sector

Pharmaceuticals

More about the company

Sector Other Pharmaceuticals

	1st Jan change	Capi.
ELI LILLY AND COMPANY	+56.86%	823B
NOVO NORDISK A/S	+40.38%	641B
JOHNSON & JOHNSON	-6.57%	352B
MERCK & CO., INC.	+17.32%	324B
ABBVIE INC.	+9.94%	301B
ASTRAZENECA PLC	+15.37%	241B
ROCHE HOLDING AG	+1.51%	223B
NOVARTIS AG	+13.66%	218B
AMGEN INC.	+7.98%	167B

Other Pharmaceuticals